Artwork

Innhold levert av Foresight Institute. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Foresight Institute eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Player FM - Podcast-app
Gå frakoblet med Player FM -appen!

Vision Weekend France: Biotech Panel

37:43
 
Del
 

Manage episode 405339924 series 2943147
Innhold levert av Foresight Institute. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Foresight Institute eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

t

Panellists: Alex Fedintsev, Leon Peshkin, Yuri Deigin, and Aleksandra Singer.

Recorded at Vision Weekend France 2023.


Key Highlights

  • They discussed the field's growth in public acceptance and funding over the past five years – they noted that, whilst reprogramming and longevity research are advancing, overall outcomes in the field haven't been as fruitful as hoped. For example, no groundbreaking concepts have emerged since reprogramming. However, they expressed optimism about the field's future, expecting gradual progress.
  • The panellists identified organ replacement, including preemptive strategies, as a key research area, as well as the potential for growth in artificially creating organs.
  • The potential integration of AI and machine learning in longevity biotech, particularly in projects like Alto Labs, was discussed.
  • They raised questions about the timeline and impact of ageing on future generations.
  • The discussion ended with an acknowledgement that, despite the optimism, much work remains in longevity biotech research.

About Foresight Institute

Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.


Allison Duettmann

The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".


Get Involved with Foresight:

Follow Us: Twitter | Facebook | LinkedIn


Note: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

168 episoder

Artwork
iconDel
 
Manage episode 405339924 series 2943147
Innhold levert av Foresight Institute. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Foresight Institute eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

t

Panellists: Alex Fedintsev, Leon Peshkin, Yuri Deigin, and Aleksandra Singer.

Recorded at Vision Weekend France 2023.


Key Highlights

  • They discussed the field's growth in public acceptance and funding over the past five years – they noted that, whilst reprogramming and longevity research are advancing, overall outcomes in the field haven't been as fruitful as hoped. For example, no groundbreaking concepts have emerged since reprogramming. However, they expressed optimism about the field's future, expecting gradual progress.
  • The panellists identified organ replacement, including preemptive strategies, as a key research area, as well as the potential for growth in artificially creating organs.
  • The potential integration of AI and machine learning in longevity biotech, particularly in projects like Alto Labs, was discussed.
  • They raised questions about the timeline and impact of ageing on future generations.
  • The discussion ended with an acknowledgement that, despite the optimism, much work remains in longevity biotech research.

About Foresight Institute

Foresight Institute is a research organization and non-profit that supports the beneficial development of high-impact technologies. Since our founding in 1987 on a vision of guiding powerful technologies, we have continued to evolve into a many-armed organization that focuses on several fields of science and technology that are too ambitious for legacy institutions to support.


Allison Duettmann

The President and CEO of Foresight Institute, Allison Duettmann directs the Intelligent Cooperation, Molecular Machines, Biotech & Health Extension, Neurotech, and Space Programs, alongside Fellowships, Prizes, and Tech Trees. She has also been pivotal in co-initiating the Longevity Prize, pioneering initiatives like Existentialhope.com, and contributing to notable works like "Superintelligence: Coordination & Strategy" and "Gaming the Future".


Get Involved with Foresight:

Follow Us: Twitter | Facebook | LinkedIn


Note: Explore every word spoken on this podcast through Fathom.fm, an innovative podcast search engine.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

168 episoder

Tutti gli episodi

×
 
Loading …

Velkommen til Player FM!

Player FM scanner netter for høykvalitets podcaster som du kan nyte nå. Det er den beste podcastappen og fungerer på Android, iPhone og internett. Registrer deg for å synkronisere abonnement på flere enheter.

 

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett